Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVGR NASDAQ:BBLG NASDAQ:BIOL NASDAQ:LGMK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVGRAvinger$0.47$0.47$0.36▼$1.93$1.57M1.291.46 million shsN/ABBLGBone Biologics$2.73-2.5%$4.06$2.65▼$18.30$1.53M0.6675,182 shs27,934 shsBIOLBIOLASE$0.01$0.02▼$1.94$581K0.672.58 million shs1,114 shsLGMKLogicMark$0.01+5.9%$0.00$0.00▼$8.74$2.94M1.4881.77 million shs13.97 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVGRAvinger0.00%0.00%0.00%0.00%-68.40%BBLGBone Biologics-2.50%-9.60%-24.59%-37.02%-78.94%BIOLBIOLASE0.00%0.00%-90.57%-92.31%-98.55%LGMKLogicMark+5.88%+58.82%+68.75%-69.14%-99.95%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVGRAvingerN/AN/AN/AN/AN/AN/AN/AN/ABBLGBone Biologics0.7796 of 5 stars0.05.00.00.00.00.01.3BIOLBIOLASE0.9473 of 5 stars3.50.00.00.00.00.00.0LGMKLogicMark0.6589 of 5 stars0.03.00.00.02.80.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVGRAvinger 0.00N/AN/AN/ABBLGBone Biologics 0.00N/AN/AN/ABIOLBIOLASE 3.00Buy$1.20∞ UpsideLGMKLogicMark 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVGRAvinger$7.65M0.21N/AN/A($4.53) per share-0.10BBLGBone BiologicsN/AN/AN/AN/A$8.39 per shareN/ABIOLBIOLASE$48.83M0.00N/AN/A($0.07) per share0.00LGMKLogicMark$9.88M0.31N/AN/A$148.65 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVGRAvinger-$18.32M-$11.06N/AN/AN/AN/AN/AN/A8/6/2025 (Estimated)BBLGBone Biologics-$4.11MN/A0.00N/AN/AN/A-130.21%-119.39%8/8/2025 (Estimated)BIOLBIOLASE-$20.63M-$14.94N/AN/AN/A-41.65%-1,782.73%-55.31%8/6/2025 (Estimated)LGMKLogicMark-$14.55M-$223.50N/A∞N/A-141.96%-124.91%-92.05%8/12/2025 (Estimated)Latest BIOL, LGMK, BBLG, and AVGR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025LGMKLogicMark-$0.03N/AN/AN/A$2.35 millionN/A8/8/2025N/ABBLGBone Biologics-$1.93N/AN/AN/AN/AN/A5/15/2025Q1 2025LGMKLogicMark-$0.03-$0.12-$0.09-$0.12$2.23 million$2.59 million5/12/2025Q1 2025BBLGBone Biologics-$2.88-$1.92+$0.96-$0.32N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVGRAvingerN/AN/AN/AN/AN/ABBLGBone BiologicsN/AN/AN/AN/AN/ABIOLBIOLASEN/AN/AN/AN/AN/ALGMKLogicMarkN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVGRAvingerN/AN/AN/ABBLGBone BiologicsN/A12.6012.60BIOLBIOLASEN/A0.710.36LGMKLogicMarkN/A3.733.29Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVGRAvinger18.30%BBLGBone Biologics34.30%BIOLBIOLASE8.79%LGMKLogicMark7.88%Insider OwnershipCompanyInsider OwnershipAVGRAvinger42.80%BBLGBone Biologics6.10%BIOLBIOLASE0.27%LGMKLogicMark2.17%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVGRAvinger703.31 million1.89 millionNot OptionableBBLGBone Biologics2550,000512,000Not OptionableBIOLBIOLASE16033.41 million33.32 millionNot OptionableLGMKLogicMark20576.31 million2.65 millionNo DataBIOL, LGMK, BBLG, and AVGR HeadlinesRecent News About These CompaniesLogicMark, Inc. to Announce Q2 2025 Financial Results and Host Investor Call on August 12, 2025July 29, 2025 | quiverquant.comQLogicMark's Holistic Approach: Leveraging Artificial Intelligence And SaaS To Protect Aging Loved OnesJune 4, 2025 | benzinga.comLogicMark, Inc. Begins Trading on OTC Markets Following Nasdaq DelistingJune 2, 2025 | quiverquant.comQLogicMark, Inc. Common Stock to Commence Trading on OTC Markets as the Company Continues Advancing Growth InitiativesJune 2, 2025 | globenewswire.comLogicMark to be delisted from NasdaqJune 1, 2025 | uk.investing.comLogicMark extends CEO’s contract, adjusts change controlMay 22, 2025 | investing.comLogicMark Extends CEO’s Term Amid Governance ChangesMay 21, 2025 | tipranks.comLogicMark reshuffles board, eyes tech-driven growthApril 29, 2025 | investing.comThese Seven Tiny Stocks Are Eating Up 72% Of Nasdaq Volume Today. Here Is The Fine Print.April 29, 2025 | investors.comLogicMark, Inc. Unveils New Board Committee Leadership Structure to Align with Strategic GoalsApril 28, 2025 | globenewswire.comLogicMark, Inc. (NASDAQ: $LGMK) Is Driving Growth Through AI-Powered Innovation!April 24, 2025 | msn.comLogicMark Stock Short Interest Report | NASDAQ:LGMK | BenzingaApril 19, 2025 | benzinga.comLGMK: Potential Revenue Catalysts: GSA Approval, Medicaid Waivers, Device UpgradesApril 8, 2025 | msn.comLogicMark Full Year 2024 Earnings: EPS Misses ExpectationsApril 2, 2025 | uk.finance.yahoo.comLogicMark secures approval to deliver new medical alter with cell phone techApril 2, 2025 | markets.businessinsider.comLogicMark Secures Approval to Deliver New Medical Alert with Cell Phone Tech to Veterans and Seniors Through U.S. General Services AdministrationApril 1, 2025 | globenewswire.comLogicMark expands capital stock capacityMarch 29, 2025 | investing.comLogicMark faces Nasdaq delisting over stock priceMarch 23, 2025 | investing.comWant To Age In Place With Confidence Or Give Your Family Peace Of Mind? LogicMark $LGMK Can Help!March 5, 2025 | msn.comLogicMark prices 2.26M units at 59c in public offeringFebruary 18, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBIOL, LGMK, BBLG, and AVGR Company DescriptionsAvinger NASDAQ:AVGR$0.47 0.00 (0.00%) As of 07/1/2025Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.Bone Biologics NASDAQ:BBLG$2.73 -0.07 (-2.50%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.73 0.00 (0.00%) As of 08/1/2025 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.BIOLASE NASDAQ:BIOLBIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.LogicMark NASDAQ:LGMK$0.0054 +0.00 (+5.88%) As of 08/1/2025 03:59 PM EasternLogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company's devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one's health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
